Heterotopic ossi®cation (HO) is a frequent complication associated with spinal cord injury. Management of HO consists of a combination of range-of-motion, diphosphonates, nonsteroidal antiin¯ammatory agents, radiation therapy, and in some cases, surgical resection. The appropriate timing of surgical resection has traditionally been based on maturity of the HO. The case presented is that of a 33-year-old male with T8 complete paraplegia who developed HO about the left hip resulting in impaired sitting. The patient underwent successful surgical wedge resection of the HO despite apparent immaturity of the HO. A comprehensive review of the literature is presented which suggests that early resection of immature HO may not be predictive of a higher recurrence rate.
Introduction
Heterotopic ossi®cation (HO), the development of bone in periarticular soft tissue, was ®rst described in spinal cord injury (SCI) by Dejerine and Ceillier in 1918. 1 The incidence of HO in SCI is reported to range from 10 ± 52%. 1 ± 11 The hallmark of medical management of HO in SCI has consisted of a combination of range-of-motion to prevent ankylosis and either a diphosphonate or nonsteroidal antiin¯ammatory agent (NSAID) to minimize the extent of ossi®cation. Despite treatment, the incidence of bony ankylosis is 5% and approximately 20% of SCI patients will experience some functional loss. 4, 12 Surgical resection of HO is undertaken in those patients in whom medical management has failed, resulting in a loss of function. Surgery is typically combined with either radiation therapy, a disphosphonate or NSAID, or both. The appropriate timing of surgical intervention has traditionally been based upon con®rmation that the HO is mature, as evidenced by bone scan, in order to reduce the risk of recurrence. Classically, the maturity of HO in SCI is felt to occur at 12 to 18 months after clinical presentation. 3 ± 5,11,12 Herein, we report the case of successful treatment of immature HO via the combination of surgical resection, radiation therapy, and a NSAID.
Case Report
The patient, a 33-year-old white male with a 9 month history of T8 complete thoracic paraplegic secondary to a pedestrian-motor vehicle accident, presented to an outpatient spinal cord injury clinic for a new patient assessment. His chief complaint was that of continued impairment in his self care and mobility. He attributed this impairment to a restriction in¯exion of his left hip that resulted from HO. HO had been diagnosed at approximately 3 months postinjury and was treated with a course of both etidronate disodium and ibuprofen. On physical examination, hip¯exion was limited to 758 by a palpable bony mass (normal 1208) ( Figure 1 ). Laboratory evaluation was unremarkable except for an elevated alkaline phosphatase of 147 (normal 39 ± 117) and elevated erythrocyte sedimentation rate (ESR) of 23 (normal 515). 99m-Tc-MDP bone scan documented continued increased uptake in the HO extending from the left iliac fossa to proximal femur (Figure 2 ). At 11 months after the diagnosis of HO, the patient underwent wedge resection of that portion of the HO residing at the level of the acetabulum (Figure 3 ). On postoperative day one, the patient received 700 cGy of radiation to the surgical site. By postoperative day seven, the surgical site was noted to be warm, erythematous, and edematous. Although feeling well, the patient was experiencing fevers up to 1038F. Laboratory evaluation was unremarkable except for an alkaline phosphatase of 158, ESR of 98, and a normal white blood cell count (WBC) of 5.9 but with 13 bands (normal 0 ± 10). Blood cultures were negative. Repeat 99m-Tc-MDP bone scan noted partial resection of the HO and was otherwise unchanged from the previous study ( Figure 4 ). The clinical and laboratory ®ndings were felt to be consistent with an acute in¯ammatory response resulting from a combination of the excision of active HO and radiation.
The surgical site did not appear infected nor the patient septic. On postoperative day seven, the patient was prescribed indomethacin 25 mg tid for 6 weeks. The fever abated within 48 h after the initiation of indomethacin and the in¯ammatory signs were completely resolved after 3 weeks of indomethacin. At 18 months after surgery, the patient has 1108 of exion at the hip and is completely independent in his self care and mobility. Radiographically, the excision site is noted to be free of HO ( Figure 5 ).
Discussion
HO in SCI is most frequently diagnosed at between 1 to 4 months postinjury with a peak incidence at 2 Clinical signs and symptoms of HO in SCI include pain, restricted joint range-of-motion, in¯ammatory signs of warmth, erythema and edema, or the development of pressure sores over the underlying HO. 99m-Tc-MDP bone scan is felt to be the most sensitive instrument for diagnosing early HO and assessing HO maturity. 13,16 ± 18 Plain roentgenograms typically reveal a¯occulent, patchy pattern of soft tissue ossi®cation 7 to 10 days after clinical symptoms arise. Although commonly elevated in HO, alkaline phosphatase levels are not speci®c to HO in SCI. 17, 18 A variety of treatment options have been described for the medical management of HO in SCI. The hallmark of treatment is range-of-motion to maintain joint function for activities such as sitting tolerance and transfers. Research has refuted the idea that active physical therapy may be a causative factor in the development of HO. 4, 5, 8 NSAIDs have been found to be of bene®t when used prophylactically for the prevention of HO or minimize its calci®cation in able-bodied patients following total joint replacement. 18 ± 20 The mechanism by which NSAIDs produce this eect is not well understood; antiprostaglandins may hinder pluripotential cells from dierentiating into osteoblasts. 19 The ecacy of NSAIDs in the prevention of HO in SCI has not been adequately studied. Diphosphonates, particularly etidronate disodium, have been shown to be of bene®t in both the prevention and treatment of HO after surgical resection as well as in minimizing the amount of calci®cation in existing HO in SCI.
3,20 ± 22 Disphosphates are believed to inhibit the incorporation of calcium phosphate into crystalline hydroxyapatite. Warfarin has recently been described as providing some bene®t in the prevention of HO. 23 The proposed mechanism of action is via inhibition of vitamin K dependent decarboxylation which is essential to the production of osteocalcin. Radiation therapy has been used successfully in preventing HO recurrence following total hip arthroplasty and as a primary treatment of HO. 24 The proposed mechanism of action is via the disruption of the dierentiation process of pluripotential cells into osteoblasts. Postoperative radiation therapy has recently been reported to decrease the recurrence of HO after surgical resection in SCI patients. 25 It should be noted that the maturity of the HO was not assessed preoperatively in this study.
Surgical resection of HO is undertaken in those patients in whom medical management has failed, resulting in a loss of function. Surgical complications are common and the risk of recurrence of HO is signi®cant. 4, 7, 17, 25 It has long been felt that the resection of HO should not occur until the HO is mature. 4, 9, 11, 15, 17, 21 However, no adequate prospective controlled studies are available to con®rm this concept. The exact timing of maturity is somewhat vague but traditionally felt to occur at 12 to 18 months after the development of HO. 4, 6, 9, 11, 20, 22 Roentgenograms are unreliable indicators of maturity. 4, 13, 17, 18, 26 Interpretation of roentgenograms is dicult and immature components may be obscured by mature bone. The assessment of maturity via roentgenograms does not correlate well with alkaline phosphatase levels either. 6 Alkaline phosphatase levels may remain elevated for years or may never return to normal. 13, 17, 18 The most sensitive indicator for maturity of HO is felt to be the 99m-Tc-MDP bone scan. 13, 16, 17, 27 A decreasing trend of activity on serial studies is felt to be indicative of maturing HO and a necessary requirement prior to surgical intervention. Bone scans may remain active for many years after the development of HO. 6 As well, bone scans, like roentgenograms, are subject to individual interpretation. 6, 27 If surgery is delayed until the bone scan reveals nonactivity in the SCI patient, the risk of fracture secondary to disuse osteopenia may increase signi®cantly. 18 Even with evidence of maturation of HO via bone scan, postsurgical recurrence rates remain high. 9, 13, 17, 18, 27 Garland's study on resection of HO concluded that normal bone scans, alkaline phosphatase levels, and mature roentogenographic appearance of HO were unreliable predictors of recurrence. 12 In studies of HO in SCI, radiographic evidence of maturity and normal alkaline phosphatase levels were of limited value in predicting recurrence. 13, 17, 27 Garland and Orwin's prospective study found little correlation between maturity rating scales and the extent of recurrence. 17 More importantly, Stover noted that the extent of recurrence was not found to be related to the length of onset of HO to surgery. 18 Studies of HO associated with traumatic brain injury (TBI) have concluded that postoperative recurrence correlated with the severity of the neurologic lesion and not with the timing of surgery. 28 Interestingly, surgical resection was undertaken despite continued activity on bone scans. No recurrence occurred postoperatively, even in those patients who underwent surgery at 5 months after the diagnosis of HO. In SCI, a complete neurologic lesion is felt to be a risk factor for the initial development of HO but has not been associated with its recurrence. 6, 14, 17 Given the confounding nature of the literature related to the determination of maturity of HO and the appropriate timing for surgical intervention especially in light of the successful resection of immature HO in TBI and our case report, we suggest that surgery need not be delayed until complete maturity occurs. Further prospective study in the treatment of immature HO using combinations of surgical resection, NSAIDs, diphosphonates, and radiation therapy is warranted.
